Sankesh Abbhi's most recent trade in Brainstorm Cell Therapeutics, Inc. was a trade of 46,779 Common Stock done at an average price of $13.0 . Disclosure was reported to the exchange on July 15, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Brainstorm Cell Therapeuti... | Sankesh Abbhi | Director | Purchase of securities on an exchange or from another person at price $ 12.99 per share. | 15 Jul 2020 | 46,779 | 2,164,530 (8%) | 0% | 13.0 | 607,659 | Common Stock |